Mitochondrial Dysfunction Pathway Alterations Offer Potential Biomarkers and Therapeutic Targets for Ovarian Cancer

Figure 4

Mechanisms of mitochondrial dysfunction pathway and mitochondria-targeted drugs in ovarian cancer.